Snowden Capital Advisors’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
CA
Snowden Capital Advisors's BME Position: Q2 2023 in Review
Snowden Capital Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2023, closing a stake of 5,360 shares — an estimated $224K sold.
Snowden Capital Advisors first reported a position in BME in Q4 2021 and held it in 6 quarters. The position peaked at $242K in Q1 2022. 69 funds tracked by Wall St. Rank hold BME as of Q2 2023.
- Snowden Capital Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2023 after selling out during the quarter.
- Snowden Capital Advisors sold 5,360 BlackRock Health Sciences Trust shares in Q2 2023, an estimated $224K.
- Snowden Capital Advisors first reported a position in BlackRock Health Sciences Trust in Q4 2021 and held it in 6 quarters.
- Snowden Capital Advisors's BlackRock Health Sciences Trust position peaked at $242K in Q1 2022.
- 69 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2023.
Based on Snowden Capital Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.